Administrative Core
Administrative Core
批准号:
10555724
负责人:
NILUFER ERTEKIN-TANER
金额:
$52.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-15 至 2028-02-29
关键词:
AccelerationAccountabilityAfrican AmericanAfrican American populationAgingAgreementAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease therapeuticAlzheimer’s disease biomarkerAmericanAutopsyBiological MarkersBloodBlood VesselsBlood specimenBrainCell NucleusCerebrospinal FluidClinicCollaborationsCommunicationCommunitiesComplexDNA MethylationDataData SetDementiaDiagnosticDisciplineDiseaseEducation and OutreachEnsureEthnic PopulationEtiologyFeedbackFundingFutureGenerationsGoalsHematological DiseaseIndianaIndividualInstitutionInstitutional Review BoardsKnowledgeKnowledge PortalLatinoLeadershipLinkMedicineMichiganMolecularMolecular ProfilingMultiomic DataNot Hispanic or LatinoOutcomeParticipantPeripheralPhenotypeProteomeReproducibilityResearchResearch PersonnelResourcesSamplingScholars ProgramScientistTrainingTraining ProgramsUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWashingtonWorkcandidate markercareercohortdata integrationdata sharingendophenotypeepigenomeinsightlipidomematerial transfer agreementmeetingsmetabolomemulti-ethnicmultiple omicsneuroimagingneuropathologynext generationopen dataoutreachprognosticprogramsrepositoryresiliencesuccesssymposiumtranscriptometranscriptome sequencingtrial readinessworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary Abstract:
“Centrally-linked Longitudinal pEripheral biomARkers of AD (CLEAR-AD) in multi-ethnic populations” is a
collaborative U19 application of >40 experts from multiple disciplines, across 13 institutions leveraging 8
independent NIH-funded cohorts of >7,000 brain and >13,000 blood samples from >3,700 individuals, in which
>20,000 multi-omics data points will be generated and integrated with >48,000 harmonized Alzheimer’s disease
(AD) endophenotypes under this U19. Our goal is to discover, replicate and validate the next-generation of AD
blood multi-omics biomarker candidates that represent molecular perturbation signatures in the brain which are
reflected in antemortem neuroimaging/cerebrospinal fluid (CSF) and post-mortem neuropathology phenotypes
of this complex disease. We aim to discover centrally-linked peripheral molecular signatures (CLPMS) that can
serve as future centrally-linked peripheral biomarkers (CLPBM) through transcriptome, epigenome, proteome,
metabolome/lipidome data generation, integration with existing other -omics data and analysis in matched
postmortem brain:antemortem blood samples (Project 1=P1); and to characterize their longitudinal dynamic
profiles in non-Hispanic white (NHW) and diverse, underrepresented populations (URP) of African American
(AA) and Latino American (LA) participants (P2, P3). We expect to identify predictive, diagnostic, prognostic and
therapeutic AD biomarkers with mechanistic insights; to enhance biomarker research in trial-ready multi-ethnic
populations and to provide the research community with a vast resource of rigorously generated, replicated and
validated multi-omics biomarkers. To achieve these aims, we will utilize and integrate existing and future data
and biospecimens from Alzheimer’s Disease Neuroimaging Initiative (ADNI), Mayo Clinic Study of Aging (MCSA)
and 6 AD Research Centers (ADRCs). The Administrative Core (Core 1: C1) will provide direction and oversight
to the projects and cores of this program (C2. Omics and C3. Analytic Cores) and facilitate their execution. The
Administrative Core will achieve the program goals through 1) integration of the participating institutions and
studies; 2) execution of all regulatory activities; 3) establishing a Diversity Scholars Program for trainees from
URPs; 4) enabling communication, outreach and knowledge sharing within the U19, with related programs, the
whole research community and public stakeholders; and 5) ensuring rigor, reproducibility and transparency by
making all data, algorithms, and outcomes available to the research community. The Specific Aims for the
Administrative Core are: 1) To provide direction, oversight, integration and facilitate execution of all U19
aims under the leadership of its Steering Committee, External Advisory Board and NIH (1a); and to execute all
regulatory activities for the program (1b). 2) To perform outreach and education by establishing a U19
Diversity Scholars Program to train AA and LA scientists (2a) and bi-annual meetings (2b). 3) To share data
and knowledge in an open-science fashion on NIH approved repositories to promote transparency,
reproducibility and reuse of all CLEAR-AD program assets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering Centrally Linked Peripheral Molecular Signatures of Alzheimer's Disease
-
批准号:10555727
-
项目类别:
-
资助金额:$97.58万
-
财政年份:2023
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10246077
-
项目类别:
-
资助金额:$323.37万
-
财政年份:2020
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.
-
批准号:10657846
-
项目类别:
-
资助金额:$98.9万
-
财政年份:2020
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10475289
-
项目类别:
-
资助金额:$242.14万
-
财政年份:2020
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10251376
-
项目类别:
-
资助金额:$318.83万
-
财政年份:2020
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10506095
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2020
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD
-
批准号:10404635
-
项目类别:
-
资助金额:$113.04万
-
财政年份:2018
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD
-
批准号:10170201
-
项目类别:
-
资助金额:$113.04万
-
财政年份:2018
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Institutional Career Development Core
-
批准号:10632366
-
项目类别:
-
资助金额:$139.53万
-
财政年份:2017
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Institutional Career Development Core
-
批准号:10674613
-
项目类别:
-
资助金额:$104.44万
-
财政年份:2017
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Genetic and Functional Analysis of Nested AD Risk Genes CTNNA3 and LRRTM3
-
批准号:8897054
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2015
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
ConProject-001
-
批准号:10176964
-
项目类别:
-
资助金额:$119.8万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A system approach to targeting innate immunity in AD
-
批准号:8735841
-
项目类别:
-
资助金额:$166.52万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Gene discovery in PSP by transcriptome, neuropathology and sequence analysis
-
批准号:8581094
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10066415
-
项目类别:
-
资助金额:$119.8万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Gene discovery in PSP by transcriptome, neuropathology and sequence analysis
-
批准号:8699857
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
Gene discovery in PSP by transcriptome, neuropathology and sequence analysis
-
批准号:8879224
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A system approach to targeting innate immunity in AD
-
批准号:9130739
-
项目类别:
-
资助金额:$159.22万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A system approach to targeting innate immunity in AD
-
批准号:9336765
-
项目类别:
-
资助金额:$176.51万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:10075683
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2013
-
负责人:NILUFER ERTEKIN-TANER
-
依托单位:
海外基金